Safar Partners
  • Approach
  • Mission
  • Team
  • Portfolio
  • News
  • Contact
Select Page

Lucy Therapeutics Receives $4.9 Million Grant from Michael J. Fox Foundation

Apr 11, 2022 | Life Sciences, Portfolio Companies, Safar News

CAMBRIDGE, Mass. — April 11, 2022 — Lucy Therapeutics (LucyTx), a biotech with a unifying mitochondrial platform, today announced it secured funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), the largest nonprofit funder of...

Aramis Biosciences Announces FDA Clearance of IND Application for A197, a Novel Immunomodulatory Agent for the Treatment of Dry Eye Disease

Jan 11, 2022 | Life Sciences, Safar News

BOSTON, Jan. 11, 2022 (GLOBE NEWSWIRE) — Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for...

Amy Ripka, CEO of Lucy Therapeutics, was recently interviewed for American Chemical Society’s Industry Matters Newsletter

Feb 15, 2021 | Life Sciences, Portfolio Companies

ACS – “Amy Ripka is CEO of Lucy Therapeutics, a Boston-based, mitochondrial platform biotech, revolutionizing treatments for rare and neurological diseases. Previous to her role at LucyTx, she served on the executive leadership teams at SAI Life Sciences...

Sharon Samjitsingh, HCO co-founder, named 2020 Tech Woman of the Year

Sep 22, 2020 | Life Sciences, Portfolio Companies

We are excited to announce that HCO co-founder Sharon Samjitsingh has been named 2020 Tech Woman of the Year by TechRochester!     2020 Tech Woman of the Year   Health Care Originals Inc. (HCO) is a leading digital health startup, integrating IoT...

Embr Wave – Empowering Aging Through Innovation

Feb 14, 2020 | AI / IT / Robotics, Life Sciences, Portfolio Companies

Forbes highlights the Safar portfolio company Embr Labs together with Singfit, a music therapy app, and Alcove VR, a virtual reality app that promotes social engagement. All three companies use technology to empower people as they age! _____________ As Americans over...

Clerio Vision Hires Eye Care Industry Veteran to Lead Cornea Commercialization Efforts

Oct 7, 2019 | Life Sciences, Portfolio Companies

ROCHESTER, N.Y., Oct. 7, 2019 /PRNewswire-PRWeb/ — Clerio Vision has named John Weberg as Cornea Chief Commercialization Officer to further expand the development of its cornea business, which includes continued research and development, clinical trials and...
« Older Entries

Archives

  • December 2022
  • October 2022
  • August 2022
  • June 2022
  • April 2022
  • February 2022
  • January 2022
  • December 2021
  • September 2021
  • August 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019

Categories

  • AI / IT / Robotics
  • Clean Tech / Advanced Materials
  • Life Sciences
  • Portfolio Companies
  • Safar News
  • Uncategorized
  • Approach
  • Mission
  • Team
  • Portfolio
  • News
  • Contact
  • Terms of Use
  • Privacy Policy